Literature DB >> 12893349

Applications of FloSeal in nephron-sparing surgery.

Herbert M User1, Robert B Nadler.   

Abstract

Hemostasis can be a challenging problem to control laparoscopically. We advocate the use of FloSeal Matrix. FloSeal can be used in a variety of open and laparoscopic procedures, including laparoscopic or open partial nephrectomy. FloSeal was highly effective in stopping bleeding in a bloody surgical field.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893349     DOI: 10.1016/s0090-4295(03)00336-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  A review of current hemostatic agents and tissue sealants used in laparoscopic partial nephrectomy.

Authors:  I Galanakis; N Vasdev; N Soomro
Journal:  Rev Urol       Date:  2011

2.  The use of novel hemostatic sealant (Tisseel) in laparoscopic myomectomy: a case-control study.

Authors:  Roberto Angioli; Francesco Plotti; Roberto Ricciardi; Corrado Terranova; Marzio Angelo Zullo; Patrizio Damiani; Roberto Montera; Federica Guzzo; Giuseppe Scaletta; Ludovico Muzii
Journal:  Surg Endosc       Date:  2012-02-01       Impact factor: 4.584

3.  Laparoscopic partial nephrectomy without intracorporeal suturing.

Authors:  Ching-Chia Li; Hsin-Chih Yeh; Hsiang-Ying Lee; Wei-Ming Li; Hung-Lung Ke; Allen Herng Shouh Hsu; Mei Hui Lee; Chia-Chun Tsai; Kuang-Shun Chueh; Chun-Nung Huang; Yii-Her Chou; Chien-Feng Li; Wen-Jeng Wu
Journal:  Surg Endosc       Date:  2015-07-11       Impact factor: 4.584

4.  The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study.

Authors:  Mario Testini; Rinaldo Marzaioli; Germana Lissidini; Agostino Lippolis; Francesco Logoluso; Angela Gurrado; Domenica Lardo; Elisabetta Poli; Giuseppe Piccinni
Journal:  Langenbecks Arch Surg       Date:  2009-05-07       Impact factor: 3.445

Review 5.  Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review.

Authors:  María Echave; Itziar Oyagüez; Miguel Angel Casado
Journal:  BMC Surg       Date:  2014-12-20       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.